Sheldon Perry

731 total citations · 1 hit paper
8 papers, 599 citations indexed

About

Sheldon Perry is a scholar working on Epidemiology, Immunology and Clinical Biochemistry. According to data from OpenAlex, Sheldon Perry has authored 8 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 3 papers in Immunology and 2 papers in Clinical Biochemistry. Recurrent topics in Sheldon Perry's work include Influenza Virus Research Studies (5 papers), Respiratory viral infections research (4 papers) and Immune Cell Function and Interaction (3 papers). Sheldon Perry is often cited by papers focused on Influenza Virus Research Studies (5 papers), Respiratory viral infections research (4 papers) and Immune Cell Function and Interaction (3 papers). Sheldon Perry collaborates with scholars based in United States, Russia and Germany. Sheldon Perry's co-authors include Benjamin L. Miller, Nathan T. Ross, Rashid Deane, Robert D. Bell, Alan E. Friedman, Itender Singh, G. Fritz, Troy J. Zarcone, Abhay P. Sagare and Berislav V. Zloković and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Tetrahedron.

In The Last Decade

Sheldon Perry

8 papers receiving 593 citations

Hit Papers

A multimodal RAGE-specific inhibitor reduces amyloid β–me... 2012 2026 2016 2021 2012 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheldon Perry United States 7 251 245 202 137 94 8 599
Rashmi Ray India 12 129 0.5× 272 1.1× 92 0.5× 250 1.8× 113 1.2× 14 645
Raquel López‐Díez United States 11 81 0.3× 218 0.9× 36 0.2× 123 0.9× 63 0.7× 15 434
Elisa Isopi Italy 9 139 0.6× 29 0.1× 66 0.3× 222 1.6× 102 1.1× 11 560
Mie Sunamoto Japan 9 183 0.7× 20 0.1× 125 0.6× 134 1.0× 192 2.0× 14 541
Sergey Trushin United States 9 207 0.8× 46 0.2× 52 0.3× 289 2.1× 82 0.9× 30 511
Lisa Emrick United States 15 134 0.5× 290 1.2× 28 0.1× 486 3.5× 27 0.3× 43 736
Atsushi Shima Japan 14 217 0.9× 239 1.0× 16 0.1× 358 2.6× 22 0.2× 38 782
Haiying Peng China 14 147 0.6× 28 0.1× 43 0.2× 216 1.6× 45 0.5× 34 617
Marika Orlov United States 7 174 0.7× 22 0.1× 57 0.3× 305 2.2× 40 0.4× 13 585
Ming Fan United States 15 152 0.6× 22 0.1× 51 0.3× 124 0.9× 74 0.8× 20 567

Countries citing papers authored by Sheldon Perry

Since Specialization
Citations

This map shows the geographic impact of Sheldon Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Perry more than expected).

Fields of papers citing papers by Sheldon Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheldon Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Perry. The network helps show where Sheldon Perry may publish in the future.

Co-authorship network of co-authors of Sheldon Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Sheldon Perry. A scholar is included among the top collaborators of Sheldon Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheldon Perry. Sheldon Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wang, Jiong, Dongmei Li, Sheldon Perry, et al.. (2021). Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains. mBio. 12(4). e0044921–e0044921. 10 indexed citations
2.
Wang, Jiong, Shannon P. Hilchey, Marta L. DeDiego, et al.. (2018). Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice. PLoS ONE. 13(4). e0193680–e0193680. 20 indexed citations
3.
Verhoeven, David, et al.. (2016). Control of influenza infection is impaired by diminished interferon-γ secretion by CD4 T cells in the lungs of toddler mice. Journal of Leukocyte Biology. 100(1). 203–212. 14 indexed citations
4.
Verhoeven, David & Sheldon Perry. (2016). Differential mucosal IL‐10‐induced immunoregulation of innate immune responses occurs in influenza infected infants/toddlers and adults. Immunology and Cell Biology. 95(3). 252–260. 6 indexed citations
5.
Wang, Jiong, Shannon P. Hilchey, Ollivier Hyrien, et al.. (2015). Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza. PLoS ONE. 10(6). e0129858–e0129858. 23 indexed citations
6.
Verhoeven, David, Sheldon Perry, & Michael E. Pichichero. (2014). Contributions to Protection from Streptococcus pneumoniae Infection Using the Monovalent Recombinant Protein Vaccine Candidates PcpA, PhtD, and PlyD1 in an Infant Murine Model during Challenge. Clinical and Vaccine Immunology. 21(8). 1037–1045. 13 indexed citations
7.
Ross, Nathan T., Rashid Deane, Sheldon Perry, & Benjamin L. Miller. (2013). Structure–activity relationships of small molecule inhibitors of RAGE-Aβ binding. Tetrahedron. 69(36). 7653–7658. 3 indexed citations
8.
Deane, Rashid, Itender Singh, Abhay P. Sagare, et al.. (2012). A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer disease. Journal of Clinical Investigation. 122(4). 1377–1392. 510 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026